Abstract:Background: Radiofrequency ablation (RFA) is effective and safe for eradicating dysplasia and intestinal metaplasia (IM) in patients with dysplastic Barrett's esophagus (BE).However, dysplasia or early cancer has been reported in the gastric cardia of patients who achieved complete eradication of intestinal metaplasia (CEIM).Our aim was to determine the prevalence of dysplasia in the endoscopically normal gastric cardia of patients who achieved CEIM in a tertiary care center.Methods: We performed a prospective cohort study of patients treated with RFA for BE who achieved CEIM at the University of North Carolina between 2012 and 2013.Data including demographics, medical history, worst histology, endoscopy findings, and complications were recorded on standardized case report forms.CEIM was defined as complete endoscopic resolution and at least one esophageal biopsy session after RFA demonstrating no IM.To assess for cardiac dysplasia, standard high resolution and narrow band imaging was performed.Then, a standardized study biopsy protocol, which included 4 quadrant biopsies at the top of the gastric folds, 1 cm into the cardia and 2 cm into the cardia (12 biopsies total) was utilized.The main outcome, the prevalence of dysplasia in the gastric cardia among patients who achieved CEIM, was calculated for the entire cohort and stratified by pre-treatment histology.Parametric and non-parametric tests were used to compare the baseline characteristics of patients who had dysplasia in gastric cardia versus patients without dysplasia.Results: 59 patients who achieved CEIM were prospectively enrolled.Of these patients, 4 (6.8%)demonstrated dysplasia in the gastric cardia.Three of these four patients had endoscopically normal appearing cardia; 1 patient had gastric nodularity.The demographic and BE baseline characteristics of patients who had dysplasia in gastric cardia were not significantly different from patients who did not demonstrate dysplasia (Table ).When stratified by worst histology prior to RFA, the prevalence of dysplasia in the gastric cardia among patients who achieved CEIM was 6.3% (1 out of 16) for patients with low-grade dysplasia, 5.7% (2 out of 35) for patients with high-grade dysplasia, and 12.5% (1 out of 8) for patients with intramucosal carcinoma.The prevalence of gastric dysplasia did not differ by worst pre-treatment BE histology (P=0.770).Conclusions: Dysplasia in the endoscopically normal gastric cardia following successful eradication of dysplastic BE is not uncommon, with an overall prevalence of 6.8%.Most cases did not have visible nodularity endoscopically.The prevalence does not differ by worst BE histology prior to RFA treatment.Routine endoscopic surveillance of post-ablation patients achieving complete eradication of intestinal metaplasia should include routine surveillance gastric cardia biopsies.The characteristics of patients with dysplasia in gastric cardia vs. patients without dysplasia in gastric cardia Mo1818

Endoscopic 3D-OCT Reveals Buried Glands Following Radiofrequency Ablation of Barrett's Esophagus

Characterization of Buried Glands Before and after Radiofrequency Ablation by Using 3-Dimensional Optical Coherence Tomography (with Videos).

Three-Dimensional Optical Coherence Tomography of Barrett'S Esophagus and Buried Glands Beneath Neosquamous Epithelium Following Radiofrequency Ablation

Structural Markers Observed with Endoscopic 3-Dimensional Optical Coherence Tomography Correlating with Barrett's Esophagus Radiofrequency Ablation Treatment Response (with Videos)

S1502: Features of Sub-Epithelial Glandular Structures on Three-Dimensional Endoscopic Optical Coherence Tomography (3D-EOCT) after Endoscopic Mucosal Ablation

Comparison of Tissue Architectural Changes Between Radiofrequency Ablation and Cryospray Ablation in Barrett'S Esophagus Using Endoscopic Three-Dimensional Optical Coherence Tomography

Computer-Aided Analysis of Gland-Like Subsurface Hyposcattering Structures in Barrett’s Esophagus Using Optical Coherence Tomography

Assessment of the Radiofrequency Ablation Dynamics of Esophageal Tissue with Optical Coherence Tomography

Three-Dimensional Optical Coherence Tomography on Endoscopic Mucosal Resection Specimens Confirms Identification of Malignant from Metaplastic Lesions in Patients with Barrett's Esophagus

Recurrent Intestinal Metaplasia after Radiofrequency Ablation for Barrett’s Esophagus: Endoscopic Findings and Anatomic Location

106 Random Biopsies in Endoscopically Normal Esophagus Improve Yield of Recurrent Intestinal Metaplasia after Successful Radiofrequency Ablation

Efficacy and Durability of Radiofrequency Ablation for Barrett's Esophagus: Systematic Review and Meta-analysis

Tu1963 Contrast Enhancement for Three-Dimensional Optical Coherence Tomography Images for Improved Delineation of Subsurface Structures

Endoscopic Three-Dimensional Optical Coherence Tomography Confirms Squamous Epithelialization Following Radiofrequency Ablation For Barrett'S Esophagus

Late Recurrence of Barrett’s Esophagus after Complete Eradication of Intestinal Metaplasia is Rare: Final Report from Ablation in Intestinal Metaplasia Containing Dysplasia Trial

Optical Biopsy Approaches in Barrett’s Esophagus with Next-Generation Optical Coherence Tomography

Cryoablation of Swine Esophageal Mucosa: A Direct Comparison to Argon Plasma Coagulation (APC) and Multipolar Electrocoagulation (MPEC)

286 Surveillance Practices in Community and Academic Settings in Patients WHO Achieve Complete Eradication of Intestinal Metaplasia (ceim) after Radiofrequency Ablation (RFA): Results from the U.S. RFA Registry

Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management

A Systematic Review and Meta-Analysis of the Treatment for Barrett’s Esophagus

Mo1817 Dysplasia in the Gastric Cardia is Not Uncommon among Patients Who Are Successful Treated by Radiofrequency Ablation for Dysplastic Barrett's Esophagus -A Prospective Study